A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

16K views

⸱

DOI:

10.3791/56930

⸱

March 28th, 2018

 ,  ,  ,  ,  , 

In This Article

Summary

Here, we present partial bile duct ligation as a surgical model of liver injury and regeneration in rodents.

Abstract

In rodents, complete bile duct ligation (cBDL) of the common bile duct is an established surgical technique for studying obstructive cholestasis and bile duct proliferation. However, long-term experiments can lead to increased morbidity and mortality. In select mouse strains with underlying liver disease, meaningful comparisons can be made even with ligation of a single lobe of the liver, which can reduce animal losses and expenses. Here, we describe partial bile duct ligation (pBDL) in the mouse, in which only the left hepatic bile duct is ligated, causing biliary obstruction in the left lobe but not the remaining lobes. With careful microsurgical technique, pBDL experiments can be cost-effective, since the unligated lobe serves as an internal control to the ligated lobes, when subjected to the same conditions in the same animal. Unlike cBDL, a separate sham-operated control group is not necessary. pBDL is highly useful to directly compare localized versus systemic effects of cholestasis and other retained bile components. pBDL can also be repurposed as a novel method to investigate mechanisms related to medications and cell migration.

Introduction

Surgical models of acute liver injury and repair, such as partial hepatectomy or common bile duct ligation (cBDL), have been used for decades in rodents to study liver regeneration and pathobiology1,2. In cBDL, the common bile duct (which drains all bile produced in the liver) is ligated, resulting in obstructive cholestasis, inflammation, and fibrosis in the first 2-3 weeks following surgery, with eventual progression to cirrhosis3. Bile duct proliferation, transdifferentiation, and induction of resident liver progenitor cells are also features of cBDL4,

Access restricted. Please log in or start a trial to view this content.

Protocol

All procedures were conducted in accordance with ethical guidelines of the Institutional Animal Care and Use Committee of the University of Pittsburgh.

1. Basic Techniques and Common Procedures

  1. Autoclave all microsurgical equipment before use.
  2. To avoid killing the mouse by anesthesia, check its breathing pattern carefully.
  3. Touch organs and intestines as little as possible to avoid damaging organs and causing bleeding. Press bleeding points with wet cotton swabs or gauze sponges.
  4. Use wet cotton swabs for gentle manipulation of organs. Wet, non-woven gauze sponges are used in two sizes, 3.5 × 3.5 cm and 6.0 × 6.....

Access restricted. Please log in or start a trial to view this content.

Results

For this typical experiment, pBDL was performed in triplicate PiZ transgenic mice, which recapitulate the human liver disease found in alpha-1 antitrypsin (A1AT) deficiency. The PiZ mouse overexpresses a transgene consisting of multiple genomic fragments of DNA that contain the coding regions of the mutant human A1AT gene and promoter, together with introns and ~2 kilobases of upstream and downstream flanking regions14,15. Normal .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Although cBDL is the most common experimental technique for obstructive cholestasis, it can present multiple challenges in rodents. Depending on the number of post-operative days required to achieve an endpoint, the animals can experience significant morbidity and mortality as time progresses. The degree of tissue injury and biliary necrosis is further exacerbated when working with some transgenic mouse models of liver disease, which demonstrate abnormal liver parenchyma and function at baseline. Compared to cBDL, report.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no disclosures.

Acknowledgements

Dr. Khan acknowledges grant support from NIH/NICHD K12HD052892, the Alpha-1 Foundation, the Hillman Foundation, and the Pittsburgh Liver Research Center. Dr. Michalopoulos acknowledges grant support from NIH/NIDDK P01DK096990. We appreciate the excellent and generous technical assistance of Anne Orr. We are also grateful to Dr. David A. Geller for providing access to the Transplant/Rodent Microsurgery lab.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Microscope-Leica Wild M650, 6–40× magnificationLeica Microsystemsn/a
Tec 3 isoflurane funnel fill vaporizerGeneral Anesthetic Servicesn/a
Stevens Tenotomy ScissorsAccurate Surgical & Scientific Instruments CorporationASSI.9193
Adson ForcepsFine science tools11006-12
Mosquito classic delicate hemostatic forcepsCodman30-4472
Micro-retractorMurdock; Roboz Surgical InstrumentRS-6550
Nonwoven gauze spongesFisherband870-PC-DBL
Puritan 6” Small Cotton Swab w/Wooden HandlePuritan Medical Products Company868-WCS
Dumont SS Forceps - Standard Tips/Straight/Inox/13.5cmFine science tools11203-23
Dumont SS Forceps - Standard Tips/Angled 45°/Inox/13.5cmFine science tools11203-25
Vannas Spring Scissors - 3mm Cutting EdgeFine science tools15000-00
Microneedle holderAesculap Surgical InstrumentsFD231R
Micro AROSuture, sterile 10-0 nylon suture, 70 µm, TAP pointsAROSurgical Instruments CorporationT4A10N07
4-0 VicrylEthiconJ662H
5-ml SyringeBD309646
Falcon tissue culture dish, 60 × 15 mmCorning353002
Isoflurane, United States Pharmacopeia (USP) liquid for inhalation, 250 mlPiramal HealthcareNDC 66794-017-25
Buprenex injectable (buprenorphine hydrochloride)Reckitt Benckiser PharmaceuticalsNDC 12496-0757-1
Cefazolin for injection , USPAPP PharmaceuticalsNDC 63323-238-61
PVP scrub solution (povidone–iodine 7.5%)MedlineNDC 12496-0757-1
70% EthanolDecon Labs2716
Phosphate Buffered Saline Without Calcium or MagnesiumLONZA17-516F
Sirius RedSigma365548
HematolxylinFisher (Richard-Allan Scientific)22-050-111 (7211)
EosinAnatech (Fisher)832 (NC9686037)
FormalinFisherSF100-20

References

  1. Higgins, G. M., Anderson, R. Experimental pathology of the liver - Restoration of the liver of the white rat following partial surgical removal. Arch Pathol. 12, 186-202 (1931).
  2. Cameron, G. R., Oakley, C. L. Ligation of the common bile duct. The Journal of Pathology and Bacteriology. 35 (5), 769-798 (1932).
  3. Kountouras, J., Billing, B. H., Scheuer, P. J.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Hepatic Bile DuctLiver RegenerationSurgical TechniqueMouse ModelLiver InjuryBile Duct ProliferationLocalized Obstruction